Evelyn Fleming

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab

Melissa M. Hardesty, Thomas C. Krivak, Gail S. Wright et al. · Gynecologic Oncology · 2022 · 99 citations · Full text

Medicine, Gynecology, Oncology +14

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Jonathan Oh, Minal Barve, Carolyn M. Matthews et al. · Gynecologic Oncology · 2016 · 90 citations

Medicine, Immunology, Oncology +16

The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.

Evelyn Fleming, Leslie A. Garrett, Whitfield B. Growdon et al. · PubMed · 2008 · 59 citations

Medicine, Oncology, Surgery +7

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)

Rebecca C. Arend, Bradley J. Monk, Ronnie Shapira‐Frommer et al. · Journal of Clinical Oncology · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +15